Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00579 | (E)-2,5-Dioxopyrrolidin-1-Yl 17-Bromo-4,7,10,13-Tetraoxaheptadec-15-En-1-Oate | 1283658-84-3 |
| (E)-2, 5-Dioxopyrrolidin-1-yl 17-bromo-4, 7, 10, 13-tetraoxaheptadec-15-en-1-oate is a PEGn linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00580 | 2,5-Dioxopyrrolidin-1-Yl 4-Methyl-4-((2-Methyl-5-Oxo-5-(2-(trimethylsilyl)ethoxy)pentan-2-Yl)disulfanyl)pentanoate | 1286715-33-0 |
| 2, 5-Dioxopyrrolidin-1-yl 4-methyl-4-((2-methyl-5-oxo-5-(2-(trimethylsilyl)ethoxy)pentan-2-yl)disulfanyl)pentanoate is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00581 | 3-((2,5-Dioxopyrrolidin-1-Yl)oxy)-3-Oxopropyl Acrylate | 1311459-55-8 |
| 3-((2, 5-Dioxopyrrolidin-1-yl)oxy)-3-oxopropyl acrylate is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00583 | mPEG9-NHS ester | 1316189-13-5 |
| m-PEG9-NHS ester is a PEG derivative containing an NHS ester. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. The hydrophilic PEG spacer increases solubility in aqueous media. m-PEG9-NHS ester is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00589 | N-Methyl-N-[(3-methyldithio)-1-oxopropyl]-L-alanine | 138148-62-6 |
| N-Methyl-N-[(3-methyldithio)-1-oxopropyl]-L-alanine, a microtubule inhibitor, is a PEG linker used in antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00599 | 2,5-Dioxopyrrolidin-1-yl 3-((3-((3-(trityloxy)propanoyl)oxy)propanoyl)oxy)propanoate | 145069-77-8 |
| 2, 5-Dioxopyrrolidin-1-yl 3-((3-((3-(trityloxy)propanoyl)oxy)propanoyl)oxy)propanoate is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00602 | Mal-L-PA-NH-Boc | 1491152-23-8 |
| Mal-L-PA-NH-Boc is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00603 | Mal-PEG3-NHS ester | 1537892-36-6 |
| Mal-PEG3-NHS ester is a non-cleavable ADC linker containing the Maleimide group. It can be used to prepare antibody conjugated drugs (ADCs). | Inquiry | |
| BADC-00616 | 2,5-Dioxopyrrolidin-1-yl 3-Hydroxypropanoate | 178106-34-8 |
| 2, 5-Dioxopyrrolidin-1-yl 3-hydroxypropanoate is a PEGn linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00628 | MAL-Tri-EG-Osu | 2055353-77-8 |
| MAL-tri-EG-Osu is a PEGn linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00636 | PDB-Pfp | 2088570-81-2 |
| Inquiry | ||
| BADC-00638 | NHPI-PEG3-C2-NHS ester | 2101206-14-6 |
| NHPI-PEG3-C2-NHS ester is a non-cleavable 3-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00639 | Ald-Ph-amido-PEG3-C2-Pfp ester | 2101206-21-5 |
| Ald-Ph-amido-PEG3-C2-Pfp ester is a PEGn linker for antibody-drug-conjugation (ADC). Ald-Ph-amido-PEG3-C2-Pfp ester is an noncleavable ADC linker, which belongs to a polyethylene glycol (PEG) linker. | Inquiry | |
| BADC-00642 | Propargyl-O-C1-amido-PEG2-C2-NHS ester | 2101206-30-6 |
| Propargyl-O-C1-amido-PEG2-C2-NHS ester is a 2-unit PEG linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00643 | NHPI-PEG2-C2-NHS ester | 2101206-31-7 |
| NHPI-PEG2-C2-NHS ester is a non-cleavable 2-unit PEG linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00644 | CHO-Ph-CONH-PEG3-NHS ester | 2101206-32-8 |
| CHO-Ph-CONH-PEG3-NHS ester is a non-cleavable 3-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs). | Inquiry | |
| BADC-00646 | PDdB-Pfp | 2101206-44-2 |
| Inquiry | ||
| BADC-00647 | Mal-amide-PEG3-CH2 NHS ester | 2101206-45-3 |
| Mal-amide-PEG3-CH2 NHS ester is a PEGn linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00648 | NHPI-PEG4-C2-PFP ester | 2101206-46-4 |
| NHPI-PEG4-C2-PFP ester is a non-cleavable 4-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs). | Inquiry | |
| BADC-00649 | NHPI-PEG2-C2-PFP ester | 2101206-47-5 |
| NHPI-PEG2-C2-PFP ester is a non-cleavable 2-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs). | Inquiry |
